Truist Securities upgraded Pacira Pharmaceuticals (NASDAQ:PCRX) stock rating from Hold to Buy, significantly raising the price target to $25.00 from the previous $8.00. The stock, currently trading at ...

Truist raised the firm’s price target on Tesla (TSLA) to $373 from $351 but keeps a Hold rating on the shares. The company’s Q4 results saw ...

Truist Securities revised its position on Cargo Therapeutics (NASDAQ:CRGX), currently trading at $13.19 with a market ...

Truist Financial analyst Michael Roxland reiterated a Buy rating on Silgan Holdings (SLGN – Research Report) today and set a price target of ...

This was the stock's second consecutive day of gains.

Net interest margin, which measures lending profitability, expanded to 3.07%, compared with 2.95% a year earlier. Truist's ...

Leaders at the bank, which has been operating in DFW for more than a decade, want to capitalize on positive trends.

Truist Financial's Q4 beat EPS and revenue estimates, but noninterest expenses rose and specific lending segments faced ...

Money from the program will be used by nonprofit groups to help rebuild small businesses, housing and infrastructure in 39 ...

Analysts at Truist Financial assumed coverage on shares of Tronox (NYSE:TROX – Get Free Report) in a research note issued to ...

Geneos Wealth Management Inc. boosted its position in shares of Truist Financial Co. (NYSE:TFC – Free Report) by 3.2% in the ...

As rights-backed securitization deals grow more prevalent in the music industry, Influence Media Partners has obtained $360 ...